Nicole R. Hadas, SVP, Chief Legal Officer at Akebia Therapeutics, Inc. (AKBA), sold 126,372 shares at $1.22 ($154K) on 2023-05-25, disclosed to the SEC on 2023-05-25.
Open-market sale of $154k AKBA by SVP, Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.22 | 63,186 | $77K | 50.0% |
| 2 | $1.22 | 63,186 | $77K | 50.0% |
| Total | $1.22 avg | 126,372 | $154K | 100% |
| Filing → |
| AKBA | SELL | 2024-02-29 | $11K | — | Filing → |
| AKBA | SELL | 2023-03-03 | $11K | — | Filing → |
| AKBA | SELL | 2023-03-01 | $5K | — | Filing → |